Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hereditary hemorrhagic telangiectasia
Symptom C0743554|recurrent epistaxis
Sentences 4
PubMedID- 25643928 Background: our previous studies have demonstrated the tolerability and low side-effect profile of office-based sclerotherapy with sodium tetradecyl sulfate (sts) for treating recurrent epistaxis due to hereditary hemorrhagic telangiectasia (hht).
PubMedID- 21743879 Statement of problem: hereditary hemorrhagic telangiectasia (hht) is associated with recurrent epistaxis in 90% of the cases.
PubMedID- 24637140 A novel approach to manage recurrent epistaxis in outpatients with hereditary hemorrhagic telangiectasia.
PubMedID- 22185213 Objective: the efforts to control recurrent epistaxis in hereditary hemorrhagic telangiectasia (hht) using alternative methods are very intense.

Page: 1